Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines

In randomized active-comparator controlled studies, DTaP5-HB-IPV-Hib showed comparable immunogenicity and safety to other licensed vaccines. This study assessed persistence of anti-hepatitis B surface antigen (HBs) and anti-pertussis antibodies, when children were 4 to 5 years of age, 3 to 4 years a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesikari, Timo, Xu, Jin, Johnson, David R., Hall, Jessie, Marček, Tomáš, Goveia, Michelle G., Acosta, Camilo J., Lee, Andrew Wen-Tseng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227712/
https://www.ncbi.nlm.nih.gov/pubmed/31689166
http://dx.doi.org/10.1080/21645515.2019.1673119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227712/
https://www.ncbi.nlm.nih.gov/pubmed/31689166
http://dx.doi.org/10.1080/21645515.2019.1673119

Ejemplares similares